bluebird bio, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 20,181 340 882
Cost of Revenue - - -
Gross Profit 20,181 340 882
Operating Expenses
Research and Development 31,002 17,210 11,409
Sales, General and Admin. 14,126 6,846 4,615
Non-Recurring Items - - -
Other - - -
Operating Income (24,947) (23,716) (15,142)
Income From Continuing Operations
Add'l Income/Expense Items (374) 46 (456)
Earnings Before Interest and Tax (25,321) (23,670) (15,598)
Interest Expense - - -
Earnings Before Tax (25,321) (23,670) (15,598)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (25,321) (23,670) (15,598)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (25,321) (23,670) (15,598)
Preferred Stock and Other Adjustments - 20,057 (4,993)
Net Income Applicable to Common Shareholders (25,321) (3,613) (20,591)